Merck’s Ebola vaccine rolled out in the Democratic Republic of Congo

Scientists have begun administering Merck’s Ebola vaccine in the Democratic Republic of Congo as part of ongoing outbreak response efforts.

The vaccine, previously used in emergency settings, is being delivered by local health teams working with international partners to protect populations at risk of infection.

Deploying the vaccine aims to curb transmission and reduce the severity of future cases, offering a hopeful tool for public‑health officials battling the disease.